• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade.

作者信息

Miller Peter G, Sperling Adam S, Gibson Christopher J, Pozdnyakova Olga, Wong Waihay J, Manos Michael P, Buchbinder Elizabeth I, Hodi F Stephen, Ebert Benjamin L, Davids Matthew S

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.

Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115.

出版信息

Haematologica. 2021 Feb 1;106(2):651-654. doi: 10.3324/haematol.2020.258426.

DOI:10.3324/haematol.2020.258426
PMID:33054119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7849751/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/7849751/3d1d55e65e7a/106651.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/7849751/1aa40cc878f3/106651.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/7849751/3d1d55e65e7a/106651.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/7849751/1aa40cc878f3/106651.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/7849751/3d1d55e65e7a/106651.fig2.jpg

相似文献

1
A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade.脾边缘区淋巴瘤对一线检查点阻断的深度分子反应。
Haematologica. 2021 Feb 1;106(2):651-654. doi: 10.3324/haematol.2020.258426.
2
NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.NOTCH信号通路在脾边缘区淋巴瘤发病机制中的作用——治疗机会
Leuk Lymphoma. 2022 Feb;63(2):279-290. doi: 10.1080/10428194.2021.1984452. Epub 2021 Sep 29.
3
Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.一名脾边缘区淋巴瘤患者在发生严重的利妥昔单抗诱导的急性血小板减少症后成功再次使用利妥昔单抗。
J Oncol Pharm Pract. 2020 Jul;26(5):1248-1253. doi: 10.1177/1078155219890023. Epub 2019 Nov 25.
4
Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema.利妥昔单抗治疗脾边缘区淋巴瘤合并获得性血管性水肿患者
Ann Allergy Asthma Immunol. 2016 May;116(5):472-3. doi: 10.1016/j.anai.2016.03.003. Epub 2016 Mar 24.
5
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.苯达莫司汀和利妥昔单抗治疗边缘区淋巴瘤的疗效：来自 II 期 BRISMA/IELSG36 研究的结果。
Br J Haematol. 2018 Dec;183(5):755-765. doi: 10.1111/bjh.15641. Epub 2018 Nov 8.
6
Splenic marginal zone B-cell lymphoma in a HIV-positive patient: a case report.一名HIV阳性患者的脾边缘区B细胞淋巴瘤：病例报告
Ann Hematol. 2009 Apr;88(4):379-81. doi: 10.1007/s00277-008-0587-4. Epub 2008 Aug 16.
7
No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.接受利妥昔单抗单药治疗后因自身免疫性溶血性贫血行脾切除术的脾边缘区淋巴瘤患者，无脾脏疾病证据。
Leuk Lymphoma. 2016 Nov;57(11):2705-8. doi: 10.3109/10428194.2016.1157877. Epub 2016 Apr 15.
8
[Rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma: a case report and literature review].[利妥昔单抗致脾边缘区淋巴瘤患者急性血小板减少症：1例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):338-342. doi: 10.3760/cma.j.issn.0253-2727.2021.04.012.
9
[Progress on Treatment of Splenic Marginal Zone Lymphoma-Review].[脾边缘区淋巴瘤治疗进展——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Apr;25(2):600-603. doi: 10.7534/j.issn.1009-2137.2017.02.053.
10
[Splenic marginal zone lymphoma complicated by cold agglutinin disease].脾边缘区淋巴瘤合并冷凝集素病
Rinsho Ketsueki. 2017;58(2):132-137. doi: 10.11406/rinketsu.58.132.

引用本文的文献

1
A phase 2 study of frontline pembrolizumab in follicular lymphoma.一项关于一线帕博利珠单抗治疗滤泡性淋巴瘤的2期研究。
EJHaem. 2024 Oct 10;5(6):1173-1181. doi: 10.1002/jha2.1029. eCollection 2024 Dec.
2
Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review.滤泡性和边缘区淋巴瘤的新型靶向药物：综述
Front Oncol. 2023 May 3;13:1170394. doi: 10.3389/fonc.2023.1170394. eCollection 2023.
3
New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas.脾脏边缘区淋巴瘤的生物学和诊断的新见解。

本文引用的文献

1
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.高通量测序揭示了血浆游离循环 DNA 变异体的来源。
Nat Med. 2019 Dec;25(12):1928-1937. doi: 10.1038/s41591-019-0652-7. Epub 2019 Nov 25.
2
A dominant-negative effect drives selection of missense mutations in myeloid malignancies.显性负效应驱动髓系恶性肿瘤中错义突变的选择。
Science. 2019 Aug 9;365(6453):599-604. doi: 10.1126/science.aax3649.
3
Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma.脾脏边缘区淋巴瘤体细胞突变的系统评价
Curr Oncol. 2021 Sep 6;28(5):3430-3447. doi: 10.3390/curroncol28050297.
4
Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma.滤泡性和边缘区淋巴瘤的无化疗管理
Cancer Manag Res. 2021 May 14;13:3935-3952. doi: 10.2147/CMAR.S267258. eCollection 2021.
Sci Rep. 2019 Jul 18;9(1):10444. doi: 10.1038/s41598-019-46906-1.
4
Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells.脾脏边缘区B细胞淋巴瘤的炎症表型，肿瘤内单核细胞/巨噬细胞和树突状细胞表达PD-L1。
Cell Mol Immunol. 2019 Jun;16(6):621-624. doi: 10.1038/s41423-019-0228-y. Epub 2019 Apr 9.
5
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.实体瘤肿瘤特异性临床基因组分析中克隆性造血基因突变的发生率。
JAMA Oncol. 2018 Nov 1;4(11):1589-1593. doi: 10.1001/jamaoncol.2018.2297.
6
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.由于克隆性造血导致的血浆基因分型假阳性。
Clin Cancer Res. 2018 Sep 15;24(18):4437-4443. doi: 10.1158/1078-0432.CCR-18-0143. Epub 2018 Mar 22.
7
Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes.程序性死亡受体-1 配体 PD-L1 和 PD-L2 在淋巴瘤亚型中表现出独特和受限的表达模式。
Hum Pathol. 2018 Jan;71:91-99. doi: 10.1016/j.humpath.2017.10.029. Epub 2017 Nov 6.
8
Putting p53 in Context.将p53置于背景中考虑。
Cell. 2017 Sep 7;170(6):1062-1078. doi: 10.1016/j.cell.2017.08.028.
9
Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.OncoPanel验证：一种用于检测癌症体细胞变异的靶向新一代测序分析方法
Arch Pathol Lab Med. 2017 Jun;141(6):751-758. doi: 10.5858/arpa.2016-0527-OA. Epub 2017 Mar 3.
10
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.帕博利珠单抗用于慢性淋巴细胞白血病（CLL）合并Richter转化或复发CLL患者。
Blood. 2017 Jun 29;129(26):3419-3427. doi: 10.1182/blood-2017-02-765685. Epub 2017 Apr 19.